Market revenue in 2023 | USD 2,301.6 million |
Market revenue in 2030 | USD 3,428.9 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Probiotics |
Fastest growing segment | Fulvic Acid |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Prebiotics, Probiotics, Enzymes, Fulvic Acid |
Key market players worldwide | Bayer AG, Herbalife Ltd, Pfizer Inc, NOW Foods, Koninklijke DSM NV, Amway Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digestive health supplements market will help companies and investors design strategic landscapes.
Probiotics was the largest segment with a revenue share of 83.06% in 2023. Horizon Databook has segmented the U.S. digestive health supplements market based on prebiotics, probiotics, enzymes, fulvic acid covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. digestive health supplements market , including forecasts for subscribers. This country databook contains high-level insights into U.S. digestive health supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account